MARIA JAMILLA LACAP: Open Payments
NPI 1578124780 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 30 payments from 8 companies in 2025. Trend: 2023 $3,271 · 2024 $1,086 · 2025 $1,496
Food & beverage: $1,496
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 16 | $660 |
| Edwards Lifesciences Corporation | 4 | $219 |
| W. L. Gore & Associates, Inc. | 3 | $213 |
| Abbott Laboratories | 1 | $143 |
| Amgen Inc. | 1 | $122 |
| Cardiac Dimensions, Inc. | 2 | $75 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
Products named: COREVALVE EVOLUT R, GORE CARDIOFORM Septal Occluder, NAVITOR, FUROSCIX, LEQVIO, GORE CARDIOFORM ASD Occluder.
Industry payments across TX — which companies pay providers there.
